Esperion Therapeutics Stock In The News
| ESPR Stock | USD 2.57 0.05 1.98% |
Our overall analysis of Esperion Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Esperion Therapeutics. The specific impact of Esperion Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Esperion Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Esperion Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Esperion Therapeutics Backtesting and Esperion Therapeutics Hype Analysis. To learn how to invest in Esperion Stock, please use our How to Invest in Esperion Therapeutics guide.
Esperion |
Esperion Therapeutics Today Top News and Investor Outlook
Esperion Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Esperion and other traded companies coverage with news coverage. We help investors stay connected with Esperion headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on Esperion Stock performance. Please note that trading solely based on the Esperion Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Esperion Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Esperion earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Esperion Therapeutics that are available to investors today. That information is available publicly through Esperion media outlets and privately through word of mouth or via Esperion internal channels. However, regardless of the origin, that massive amount of Esperion data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Esperion Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Esperion Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Esperion Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Esperion Therapeutics alpha.
Esperion Largest EPS Surprises
Earnings surprises can significantly impact Esperion Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-05 | 2024-09-30 | -0.18 | -0.15 | 0.03 | 16 | ||
2023-11-07 | 2023-09-30 | -0.43 | -0.37 | 0.06 | 13 | ||
2015-03-05 | 2014-12-31 | -0.55 | -0.49 | 0.06 | 10 | ||
2013-11-06 | 2013-09-30 | -0.4 | -0.34 | 0.06 | 15 | ||
2015-05-07 | 2015-03-31 | -0.48 | -0.56 | -0.08 | 16 | ||
2016-05-04 | 2016-03-31 | -0.74 | -0.65 | 0.09 | 12 |
Esperion Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Esperion Therapeutics Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
21st of November 2024
Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference at gurufocus.com
18th of November 2024
Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of N... at globenewswire.com
8th of November 2024
Esperion Therapeutics Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth Amidst ..... at gurufocus.com
7th of November 2024
Esperions Q3 Loss Wider Than Expected, Revenues Rise YY at zacks.com
5th of November 2024
Vanguard Group Incs Strategic Acquisition in Esperion Therapeutics Inc at gurufocus.com
31st of October 2024
Esperion Therapeutics May Report Negative Earnings Know the Trend Ahead of Next Weeks Rele... at zacks.com
17th of October 2024
Disposition of 107 shares by Warren Eric of Esperion Therapeutics at 2.119 subject to Rule... at gurufocus.com
18th of September 2024
Esperion CEO Sheldon Koenig sells shares worth over 26k at investing.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Esperion Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Esperion Therapeutics' short interest history, or implied volatility extrapolated from Esperion Therapeutics options trading.
Additional Tools for Esperion Stock Analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.